MarketBeat Instant News Alerts 2 hours agoEnergizer (NYSE:ENR) Earns Neutral Rating from UBS GroupMarketBeatUBS Group raised their target price on Energizer from $23.00 to $29.00 and gave the stock a "neutral" rating in a research note on Tuesday.NYSE:ENRRead Energizer (NYSE:ENR) Earns Neutral Rating from UBS Group2 hours agoBrookfield Business Partners (NYSE:BBU) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysMarketBeatRoyal Bank Of Canada lifted their price target on Brookfield Business Partners from $33.00 to $35.00 and gave the stock an "outperform" rating in a report on Tuesday.NYSE:BBURead Brookfield Business Partners (NYSE:BBU) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says2 hours agoB&G Foods (NYSE:BGS) Price Target Lowered to $5.00 at Royal Bank Of CanadaMarketBeatRoyal Bank Of Canada lowered their price objective on shares of B&G Foods from $6.00 to $5.00 and set a "sector perform" rating on the stock in a report on Tuesday.NYSE:BGSRead B&G Foods (NYSE:BGS) Price Target Lowered to $5.00 at Royal Bank Of Canada2 hours agoMr. Cooper Group (NASDAQ:COOP) Receives Neutral Rating from UBS GroupMarketBeatUBS Group lifted their price target on Mr. Cooper Group from $156.00 to $178.00 and gave the company a "neutral" rating in a research report on Tuesday.NASDAQ:COOPRead Mr. Cooper Group (NASDAQ:COOP) Receives Neutral Rating from UBS Group2 hours agoRoyal Bank Of Canada Issues Positive Forecast for Axsome Therapeutics (NASDAQ:AXSM) Stock PriceMarketBeatRoyal Bank Of Canada boosted their target price on Axsome Therapeutics from $184.00 to $189.00 and gave the company an "outperform" rating in a report on Tuesday.NASDAQ:AXSMRead Royal Bank Of Canada Issues Positive Forecast for Axsome Therapeutics (NASDAQ:AXSM) Stock Price2 hours agoCabot (NYSE:CBT) PT Set at $82.00 by UBS GroupMarketBeatUBS Group lifted their price objective on shares of Cabot from $81.00 to $82.00 and gave the stock a "neutral" rating in a research report on Tuesday.NYSE:CBTRead Cabot (NYSE:CBT) PT Set at $82.00 by UBS Group Trending News1CRISPR Therapeutics (NASDAQ:CRSP) Issues Quarterly Earnings Results, Beats Estimates By $0.18 EPS2Archer Aviation (ACHR) Projected to Post Earnings on Monday3Federated Hermes Inc. Acquires 1,122,535 Shares of Virgin Galactic Holdings, Inc. (NYSE:SPCE)4Archer Aviation (NYSE:ACHR) Trading Up 4.1% on Analyst Upgrade5AST SpaceMobile (ASTS) Expected to Announce Earnings on Monday6Lloyds Banking Group (NYSE:LYG) Raised to Neutral at JPMorgan Chase & Co.7Carol B. Tome Acquires 11,682 Shares of United Parcel Service, Inc. (NYSE:UPS) Stock8Fannie Mae (OTCMKTS:FNMA) Shares Gap Up - Should You Buy? All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Alert Type Keywords 2 hours agoUBS Group Forecasts Strong Price Appreciation for BioMarin Pharmaceutical (NASDAQ:BMRN) StockMarketBeatNASDAQ:BMRNRead UBS Group Forecasts Strong Price Appreciation for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock2 hours agoAptiv (NYSE:APTV) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysMarketBeatNYSE:APTVRead Aptiv (NYSE:APTV) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says2 hours agoBirkenstock (NYSE:BIRK) Given a $77.00 Price Target by UBS Group AnalystsMarketBeatNYSE:BIRKRead Birkenstock (NYSE:BIRK) Given a $77.00 Price Target by UBS Group Analysts2 hours agoAxon Enterprise (NASDAQ:AXON) Given Neutral Rating at UBS GroupMarketBeatNASDAQ:AXONRead Axon Enterprise (NASDAQ:AXON) Given Neutral Rating at UBS Group2 hours agoSelective Insurance Group (NASDAQ:SIGI) Given a $88.00 Price Target by BMO Capital Markets AnalystsMarketBeatNASDAQ:SIGIRead Selective Insurance Group (NASDAQ:SIGI) Given a $88.00 Price Target by BMO Capital Markets Analysts2 hours agoSBA Communications (NASDAQ:SBAC) Given a $280.00 Price Target at JMP SecuritiesMarketBeatNASDAQ:SBACRead SBA Communications (NASDAQ:SBAC) Given a $280.00 Price Target at JMP Securities2 hours agoWayfair (NYSE:W) Given a $68.00 Price Target by Stifel Nicolaus AnalystsMarketBeatNYSE:WRead Wayfair (NYSE:W) Given a $68.00 Price Target by Stifel Nicolaus Analysts2 hours agoVertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $530.00 by BMO Capital MarketsMarketBeatNASDAQ:VRTXRead Vertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $530.00 by BMO Capital Markets2 hours agoD. Boral Capital Reaffirms Buy Rating for Urogen Pharma (NASDAQ:URGN)MarketBeatNASDAQ:URGNRead D. Boral Capital Reaffirms Buy Rating for Urogen Pharma (NASDAQ:URGN)2 hours agoPRA Group (NASDAQ:PRAA) Given a $24.00 Price Target by JMP Securities AnalystsMarketBeatNASDAQ:PRAARead PRA Group (NASDAQ:PRAA) Given a $24.00 Price Target by JMP Securities Analysts2 hours agoJPMorgan Chase & Co. Lowers Lithia Motors (NYSE:LAD) Price Target to $315.00MarketBeatNYSE:LADRead JPMorgan Chase & Co. Lowers Lithia Motors (NYSE:LAD) Price Target to $315.002 hours agoVimeo's (VMEO) "Overweight" Rating Reaffirmed at Piper SandlerMarketBeatNASDAQ:VMEORead Vimeo's (VMEO) "Overweight" Rating Reaffirmed at Piper Sandler2 hours agoDenny's (NASDAQ:DENN) Given a $4.00 Price Target at Piper SandlerMarketBeatNASDAQ:DENNRead Denny's (NASDAQ:DENN) Given a $4.00 Price Target at Piper Sandler2 hours agoJMP Securities Issues Positive Forecast for ODDITY Tech (NASDAQ:ODD) Stock PriceMarketBeatNASDAQ:ODDRead JMP Securities Issues Positive Forecast for ODDITY Tech (NASDAQ:ODD) Stock Price2 hours agoWolverine World Wide (NYSE:WWW) Receives "Overweight" Rating from Piper SandlerMarketBeatNYSE:WWWRead Wolverine World Wide (NYSE:WWW) Receives "Overweight" Rating from Piper Sandler2 hours agoInspire Medical Systems (NYSE:INSP) PT Set at $150.00 by Piper SandlerMarketBeatNYSE:INSPRead Inspire Medical Systems (NYSE:INSP) PT Set at $150.00 by Piper Sandler2 hours agoJMP Securities Begins Coverage on Quince Therapeutics (NASDAQ:QNCX)MarketBeatNASDAQ:QNCXRead JMP Securities Begins Coverage on Quince Therapeutics (NASDAQ:QNCX)2 hours agoBank of America Raises Pfizer (NYSE:PFE) Price Target to $28.00MarketBeatNYSE:PFERead Bank of America Raises Pfizer (NYSE:PFE) Price Target to $28.002 hours agoDomino's Pizza Group (LON:DOM) Shares Down 16.2% - What's Next?MarketBeatLON:DOMRead Domino's Pizza Group (LON:DOM) Shares Down 16.2% - What's Next?2 hours agoSynthomer (LON:SYNT) Trading Down 17.5% - Should You Sell?MarketBeatLON:SYNTRead Synthomer (LON:SYNT) Trading Down 17.5% - Should You Sell?2 hours agoKinross Gold (TSE:K) Rating Increased to Strong-Buy at UBS GroupMarketBeatTSE:KRead Kinross Gold (TSE:K) Rating Increased to Strong-Buy at UBS Group2 hours agoMasTec (NYSE:MTZ) Rating Increased to Strong-Buy at Baird R WMarketBeatNYSE:MTZRead MasTec (NYSE:MTZ) Rating Increased to Strong-Buy at Baird R W2 hours agoShell (NYSE:SHEL) Cut to Hold at Hsbc Global ResMarketBeatNYSE:SHELRead Shell (NYSE:SHEL) Cut to Hold at Hsbc Global Res2 hours agoFortrea (NASDAQ:FTRE) Raised to "Strong-Buy" at Baird R WMarketBeatNASDAQ:FTRERead Fortrea (NASDAQ:FTRE) Raised to "Strong-Buy" at Baird R W Featured Articles and OffersThis Drone Stock Is on Sale Despite Big Army ContractBy Jeffrey Neal Johnson | July 31, 2025View This Drone Stock Is on Sale Despite Big Army ContractElon’s BIGGEST warning yet?From Brownstone Research(Ad)View Elon’s BIGGEST warning yet?5 Stocks to Buy in August With Tremendous Upside PotentialBy Thomas Hughes | July 31, 2025View 5 Stocks to Buy in August With Tremendous Upside PotentialBitcoin and Dividends: A Winning Combo in These 3 ETFsBy Nathan Reiff | August 2, 2025View Bitcoin and Dividends: A Winning Combo in These 3 ETFsGolden Cross Alert: 3 Stocks With Serious Upside PotentialBy Chris Markoch | July 31, 2025View Golden Cross Alert: 3 Stocks With Serious Upside Potential[No Brainer Gold Play]: “Show me a better investment.”From Golden Portfolio(Ad)View [No Brainer Gold Play]: “Show me a better investment.”Rocket Lab Reports Next Week: Here’s What Investors Should KnowBy Ryan Hasson | August 1, 2025View Rocket Lab Reports Next Week: Here’s What Investors Should Know2 Cybersecurity Giants Nearing Big Potential BreakoutsBy Ryan Hasson | July 31, 2025View 2 Cybersecurity Giants Nearing Big Potential Breakouts Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
